Design, synthesis and molecular modeling of pyrazole–quinoline–pyridine hybrids as a new class of antimicrobial and anticancer agents CB Sangani, JA Makawana, X Zhang, SB Teraiya, L Lin, HL Zhu European Journal of Medicinal Chemistry 76, 549-557, 2014 | 131 | 2014 |
Microwave assisted synthesis of novel 4H-chromene derivatives bearing phenoxypyrazole and their antimicrobial activity assess CB Sangani, NM Shah, MP Patel, RG Patel Journal of the Serbian chemical society 77 (9), 1165-1174, 2012 | 113 | 2012 |
Synthesis, biological evaluation and 3D-QSAR study of novel 4, 5-dihydro-1H-pyrazole thiazole derivatives as BRAFV600E inhibitors MY Zhao, Y Yin, XW Yu, CB Sangani, SF Wang, AM Lu, LF Yang, PC Lv, ... Bioorganic & medicinal chemistry 23 (1), 46-54, 2015 | 62 | 2015 |
Schiff’s base derivatives bearing nitroimidazole and quinoline nuclei: New class of anticancer agents and potential EGFR tyrosine kinase inhibitors JA Makawana, CB Sangani, L Lin, HL Zhu Bioorganic & medicinal chemistry letters 24 (7), 1734-1736, 2014 | 57 | 2014 |
One step synthesis of pyrido [1, 2-a] benzimidazole derivatives of aryloxypyrazole and their antimicrobial evaluation HH Jardosh, CB Sangani, MP Patel, RG Patel Chinese Chemical Letters 24 (2), 123-126, 2013 | 51 | 2013 |
Synthesis and antimicrobial screening of pyrano [3, 2-c] chromene derivatives of 1H-pyrazoles C Sangani, D Mungra, M Patel, R Patel Open Chemistry 9 (4), 635-647, 2011 | 45 | 2011 |
Synthesis and in vitro antimicrobial screening of new pyrano [4, 3-b] pyrane derivatives of 1H-pyrazole CB Sangani, DC Mungra, MP Patel, RG Patel Chinese Chemical Letters 23 (1), 57-60, 2012 | 43 | 2012 |
Design, synthesis and molecular modeling of biquinoline–pyridine hybrids as a new class of potential EGFR and HER-2 kinase inhibitors CB Sangani, JA Makawana, YT Duan, Y Yin, SB Teraiya, NJ Thumar, ... Bioorganic & Medicinal Chemistry Letters 24 (18), 4472-4476, 2014 | 39 | 2014 |
Microwave-assisted synthesis of pyrido[1,2-a]benzimidazole derivatives of β-aryloxyquinoline and their antimicrobial and antituberculosis activities CB Sangani, HH Jardosh, MP Patel, RG Patel Medicinal Chemistry Research 22, 3035-3047, 2013 | 34 | 2013 |
An overview of privileged scaffold: quinolines and isoquinolines in medicinal chemistry as anticancer agents Y Mao, K Soni, C Sangani, Y Yao Current Topics in Medicinal Chemistry 20 (28), 2599-2633, 2020 | 32 | 2020 |
6, 7-Dihydrobenzo [f] benzo [4, 5] imidazo [1, 2-d][1, 4] oxazepine derivatives as selective inhibitors of PI3Kα Y Yin, YQ Zhang, B Jin, S Sha, X Wu, CB Sangani, SF Wang, F Qiao, ... Bioorganic & Medicinal Chemistry 23 (6), 1231-1240, 2015 | 32 | 2015 |
Synthesis of 1H-pyrazolo[1,2-b]phthalazine-5,10-dione derivatives: assessment of their antimicrobial, antituberculosis and antioxidant activity CB Sangani, JA Makwana, YT Duan, NJ Thumar, MY Zhao, YS Patel, ... Research on Chemical Intermediates 42, 2101-2117, 2016 | 31 | 2016 |
New promises to cure cancer and other genetic diseases/disorders: epi-drugs through epigenetics YT Duan, CB Sangani, W Liu, KV Soni, Y Yao Current Topics in Medicinal Chemistry 19 (12), 972-994, 2019 | 23 | 2019 |
Recent developments in the synthesis of pyrido [1, 2-a] benzimidazoles R Khajuria, S Rasheed, C Khajuria, KK Kapoor, P Das Synthesis 50 (11), 2131-2149, 2018 | 23 | 2018 |
Microwave-assisted synthesis of novel 4H-chromene derivatives bearing 2-aryloxyquinoline and their antimicrobial activity assessment CB Sangani, NM Shah, MP Patel, RG Patel Medicinal Chemistry Research 22, 3831-3842, 2013 | 19 | 2013 |
Catalyst-free synthesis of fused triazolo-diazepino [5, 6-b] quinoline derivatives via a sequential Ugi-4CR–nucleophilic substitution–intramolecular Click reaction S Balalaie, A Vaezghaemi, N Zarezadeh, F Rominger, HR Bijanzadeh Synlett 29 (08), 1095-1101, 2018 | 18 | 2018 |
Thermal, SEM, AFM, BET and biological analysis of newly synthesized Fe2+/Fe3+ based MOIFs YT Duan, CB Sangani, RK Ameta Journal of Molecular Liquids 295, 111709, 2019 | 14 | 2019 |
Copper acetate aerobic oxidative synthesis of pyrido [1, 2-a] benzimidazoles from aminopyridines and phenylboronic acids H Yan, H Guo, X Zhou, Z Zuo, J Liu, G Zhang, S Zhang Synlett 30 (12), 1469-1473, 2019 | 14 | 2019 |
Bromodomain and BET family proteins as epigenetic targets in cancer therapy: their degradation, present drugs, and possible PROTACs M Muddassir, K Soni, CB Sangani, A Alarifi, M Afzal, NAY Abduh, Y Duan, ... RSC advances 11 (2), 612-636, 2021 | 13 | 2021 |
Recent developments of metal and metal oxide nanocatalysts in organic synthesis J A Makawana, C B Sangani, YF Yao, YT Duan, PC Lv, HL Zhu Mini Reviews in Medicinal Chemistry 16 (16), 1303-1320, 2016 | 12 | 2016 |